文献
J-GLOBAL ID:202202248832134355
整理番号:22A0981993
高齢者における血漿p-tau231,p-tau181,PETバイオマーカーおよび認知変化【JST・京大機械翻訳】
Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults
著者 (39件):
Meyer Pierre-Francois
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Ashton Nicholas J.
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Ashton Nicholas J.
(Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden)
,
Ashton Nicholas J.
(King’s College London, Institute of Psychiatry, Psychology & Neuroscience, Maurice Wohl Clinical Neuroscience Institute, London, UK)
,
Ashton Nicholas J.
(NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK)
,
Karikari Thomas K.
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Karikari Thomas K.
(NIHR Biomedical Research Centre for Mental Health & Biomedical Research Unit for Dementia at South London & Maudsley NHS Foundation, London, UK)
,
Strikwerda-Brown Cherie
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Kobe Theresa
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Gonneaud Julie
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Pichet Binette Alexa
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Pichet Binette Alexa
(Department of Psychiatry, McGill University, Montreal, Quebec, Canada)
,
Pichet Binette Alexa
(McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada)
,
Ozlen Hazal
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Yakoub Yara
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Simren Joel
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Simren Joel
(Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden)
,
Pannee Josef
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Pannee Josef
(Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden)
,
Lantero-Rodriguez Juan
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Labonte Anne
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Baker Suzanne L.
(Molecular Biophysics and Integrated Bioimaging, Lawrence Berkeley National Laboratory, Berkeley, CA)
,
Scholl Michael
(Wallenberg Centre for Molecular and Translational Medicine, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Gothenburg, Sweden)
,
Vanmechelen Eugeen
(ADx NeuroSciences, Ghent, Belgium)
,
Breitner John C. S.
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Breitner John C. S.
(Department of Psychiatry, McGill University, Montreal, Quebec, Canada)
,
Breitner John C. S.
(McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada)
,
Zetterberg Henrik
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Zetterberg Henrik
(Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden)
,
Zetterberg Henrik
(Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, University College London, London, UK)
,
Zetterberg Henrik
(UK Dementia Research Institute at UCL, London, UK)
,
Blennow Kaj
(Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden)
,
Blennow Kaj
(Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Molndal, Sweden)
,
Poirier Judes
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Poirier Judes
(Department of Psychiatry, McGill University, Montreal, Quebec, Canada)
,
Villeneuve Sylvia
(Douglas Mental Health University Institute, Centre for Studies on Prevention of Alzheimer’s Disease (StoP-AD), Montreal, Quebec, Canada)
,
Villeneuve Sylvia
(Department of Psychiatry, McGill University, Montreal, Quebec, Canada)
,
Villeneuve Sylvia
(McGill Centre for Integrative Neuroscience, McGill University, Montreal, Quebec, Canada)
,
Villeneuve Sylvia
(Department of Neurology and Neurosurgery, McGill University, Montreal, Quebec, Canada)
資料名:
Annals of Neurology
(Annals of Neurology)
巻:
91
号:
4
ページ:
548-560
発行年:
2022年
JST資料番号:
T0008A
ISSN:
0364-5134
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)